Neoadjuvant anti-programmed Death-1 immunotherapy by Pembrolizumab in resectable nodal positive stage II/IIIa non-small-cell lung cancer (NSCLC): the NEOMUN trial
Document type:
Zeitschriftenaufsatz
Author(s):
Eichhorn, Florian; Klotz, Laura V.; Bischoff, Helge; Thomas, Michael; Lasitschka, Felix; Winter, Hauke; Hoffmann, Hans; Eichhorn, Martin E.